60 DEGREES PHARMACEUTICALS, INC. 8-KCurrent Reports (8-K / ad hoc)

Changes / Accountants

Item 9.01 Financial Statements and Exhibits (a) Exhibits Number Description 99.1 60 Degrees Pharmaceuticals, Inc. Investor Presentation, dated September 8, 2026 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) Field: Page; Sequence: 2; Options: NewSection; Value: 1 Field: Sequence; Type: Arabic; Name: PageNo 1 Field: /Sequence Field: /Page SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. 60 DEGREES PHARMACEUTICALS, INC. Date: September 8, 2026 By: /s/ Geoffrey Dow Name: Geoffrey Dow Title: Chief Executive Officer and President Field: Page; Sequence: 3; Options: Last Field: Sequence; Type: Arabic; Name: PageNo 2 Field: /Sequence Field: /Page Field: Set; Name: xdx; ID: xdx_08B_extensions eJx1kd1OwzAMhZ9g72BVXFZbWokhegfVmBAbq7ZpcGs6l1Vr48pJ9/NIvCVpugkuIIqUOPb5fKwEQRhM+amsSOD9cTmDNdVNhZZgSQUJ6ZxcRfr8koA7l/RZGiuorQ+vwpSdhpxmPLxF9+4rD6WhbQLqbhSrUTwGFSXRPWTzYNDlU9ZFuSVtS6wA9RYy4UZKsijnnrDGE2uuz77ThsSUrBOIhqpPf0Gsohhe+YBHlr2B2SwNBqFfg2Aq3DauanKypDslTCqqXTvTq3+2d5O3xnKdvKF0s5kJ5rvLfc1ZK/kODS00rXYotCjcuDXrleV8P6f6g8QRIhXHkXq4mLuCQiCHgmMfgmVoLjRgTWA6HnABPRE88g9fvxpmKBusWlJDpVSUkXhP/9j4jQ2hQYFDp4WbXg2N+zvv4drzG36hoMA=